Sinopharm sells $526 million of new H-shares

The Chinese drugs distributor completes the fourth-biggest equity capital-raising in Asia this year through a private placement, while Shui On Land announces a rights issue of at least $474 million.
<div style="text-align: left;"> The Sinopharm group is China’s biggest distributor of pharmaceutical and medical products </div>
<div style="text-align: left;"> The Sinopharm group is China’s biggest distributor of pharmaceutical and medical products </div>
April 02, 2013

Hong Kong-listed Sinopharm Group, China’s biggest distributor of pharmaceutical products, has raised HK$4.08 billion ($526 million) from a private placement ― its second such deal in two years.

¬ Haymarket Media Limited. All rights reserved.

Sign in to read on!

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].

Share our publication on social media
Share our publication on social media